These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1989952)

  • 1. Cancer dose-response in A-bomb survivors: erroneous basis of Izatt's 'fairly conclusive evidence' for hormesis.
    Gofman JW
    Health Phys; 1991 Feb; 60(2):281-2. PubMed ID: 1989952
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to 'Supra-linear dose-response in the A-bomb study'.
    Izatt JA
    Health Phys; 1991 Feb; 60(2):281. PubMed ID: 1989951
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on the article "Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990" by D. A. Pierce, Y. Shimizu. D. L. Preston, M. Vaeth and K. Mabuchi (Radiat. Res. 146, 1-27, 1996).
    Little MP
    Radiat Res; 1997 Oct; 148(4):399-401. PubMed ID: 9339957
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response analyses for the Japanese A-bomb survivors.
    Muirhead CR; Butland BK
    Health Phys; 1989 Dec; 57(6):1035-6. PubMed ID: 2584020
    [No Abstract]   [Full Text] [Related]  

  • 9. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-at-exposure effects on risk estimates for non-cancer mortality in the Japanese atomic bomb survivors.
    Zhang W; Muirhead CR; Hunter N
    J Radiol Prot; 2005 Dec; 25(4):393-404. PubMed ID: 16340068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of relative biological effectiveness dependence on linear energy transfer for low-LET radiations.
    Hunter N; Muirhead CR
    J Radiol Prot; 2009 Mar; 29(1):5-21. PubMed ID: 19225189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The shape of the cancer mortality dose-response curve for the A-bomb survivors.
    Pierce DA; Vaeth M
    Radiat Res; 1991 Apr; 126(1):36-42. PubMed ID: 2020737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis.
    Kai M; Luebeck EG; Moolgavkar SH
    Radiat Res; 1997 Oct; 148(4):348-58. PubMed ID: 9339951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More about cancer incidence in atomic bomb survivors: solid tumors, 1958-1987.
    Ron E; Preston DL; Mabuchi K
    Radiat Res; 1995 Jan; 141(1):126-7. PubMed ID: 7997509
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis.
    Kyoizumi S; Akiyama M; Cologne JB; Tanabe K; Nakamura N; Awa AA; Hirai Y; Kusunoki Y; Umeki S
    Radiat Res; 1996 Jul; 146(1):43-52. PubMed ID: 8677297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold.
    Neriishi K; Nakashima E; Minamoto A; Fujiwara S; Akahoshi M; Mishima HK; Kitaoka T; Shore RE
    Radiat Res; 2007 Oct; 168(4):404-8. PubMed ID: 17903036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study.
    Howe GR; McLaughlin J
    Radiat Res; 1996 Jun; 145(6):694-707. PubMed ID: 8643829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. on: 'No evidence for increased tumor rates below 200 mSv in the atomic bomb survivors' data'.
    Pierce DA; Preston DL
    Radiat Environ Biophys; 1997 Sep; 36(3):209-10; discussion 211-2. PubMed ID: 9402639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.